创伤性脑损伤后早期氨甲环酸可防止血脑屏障高通透性并改善神经临床恢复的替代指标
该研究为小鼠实验,35只CD1雄性小鼠随机分为重度TBI(控制性皮层撞击)或假手术,伤后1小时静脉注射生理盐水(安慰剂)、伤后1小时或24小时给予氨甲环酸(30 mg/kg)。伤后48小时行活体软脑膜 intravital 显微镜观察白细胞-内皮细胞相互作用及血脑屏障荧光白蛋白渗漏,并以Garcia神经学测试和体重恢复评估神经临床恢复。结果显示仅伤后1小时氨甲环酸改善伤后第1天Garcia测试表现,1小时与24小时均改善第1天体重恢复,但仅1小时组改善第2天体重恢复(p=0.04);各组白细胞滚动或黏附无组间差异,仅1小时氨甲环酸降低血脑屏障通透性。作者认为氨甲环酸保护血脑屏障完整性的效应具有时间敏感性,支持仅早期给药。
要点
- 小鼠重度TBI后仅伤后1小时静脉给予氨甲环酸30 mg/kg可降低血脑屏障通透性,伤后24小时给药无此效应。
- 伤后1小时氨甲环酸改善伤后第1天Garcia神经学测试表现,24小时给药与安慰剂相比无此改善。
- 伤后1小时与24小时氨甲环酸均改善伤后第1天体重恢复,但仅1小时组改善第2天体重恢复(p=0.04)。
- 各损伤组间白细胞滚动或黏附无差异,提示氨甲环酸的血脑屏障保护效应似乎不依赖白细胞-内皮细胞相互作用。
- 作者结论支持仅早期(伤后1小时)给予氨甲环酸,该时间敏感性效应在动物模型中观察到。
适用人群与场景
- CD1雄性小鼠(n=35),重度创伤性脑损伤(控制性皮层撞击:速度6 m/s、深度1 mm、直径3 mm)或假开颅手术模型。
- 动物实验场景,非人类急诊或ICU患者。
处置流程与药物剂量
- 伤后1小时静脉给予氨甲环酸30 mg/kg,或伤后24小时静脉给予氨甲环酸30 mg/kg;对照组伤后1小时静脉给予生理盐水(安慰剂)。
- 伤后48小时行活体软脑膜 intravital 显微镜观察白细胞-内皮细胞相互作用及血脑屏障微血管荧光白蛋白渗漏。
- 伤后第1天和第2天以Garcia神经学测试(运动、感觉、反射和平衡评估)及体重丢失恢复评估神经临床恢复。
研究设计与关键结果
- 研究类型:动物实验,CD1雄性小鼠(n=35)随机分组。
- 与安慰剂相比,伤后1小时氨甲环酸改善伤后第1天Garcia神经学测试表现,伤后24小时氨甲环酸无此改善。
- 伤后1小时与24小时氨甲环酸均改善伤后第1天体重丢失恢复,但仅伤后1小时氨甲环酸较安慰剂显著改善伤后第2天体重丢失恢复(p=0.04)。
- 损伤动物组间白细胞滚动或黏附未见组间差异。
- 与未治疗损伤动物相比,仅伤后1小时氨甲环酸降低血脑屏障通透性。
证据类型、等级与局限
- 证据类型:动物实验(小鼠在体研究)。
- 统计方法:方差分析(ANOVA)结合Bonferroni校正评估组间差异,p<0.05。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该时间敏感性效应支持仅早期(伤后1小时)给予氨甲环酸,伤后24小时给药无一致神经恢复获益。
- 该结果为小鼠模型,不能直接作为人类急诊或ICU的用药推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Tranexamic acid (TXA) given early, but not late, after traumatic brain injury (TBI) appears to improve survival. This may be partly related to TXA-driven profibrinolysis and increased leukocyte (LEU)-mediated inflammation when administered late post-injury. We hypothesized that early TXA (1 hour post-TBI), blunts penumbral, blood-brain barrier (BBB) leukocyte-endothelial cell (LEU-EC) interactions and microvascular permeability, in vivo when compared with late administration (24 hours post-TBI).
METHODS: CD1 male mice (n = 35) were randomized to severe TBI (injury by controlled cortical impact; injury: velocity, 6 m/s; depth, 1 mm; diameter, 3 mm) or sham craniotomy followed by intravenous saline (placebo) at 1 hour, or TXA (30 mg/kg) at 1 hour or 24 hours. At 48 hours, in vivo pial intravital microscopy visualized live penumbral LEU-EC interactions and BBB microvascular fluorescent albumin leakage. Neuroclinical recovery was assessed by the Garcia Neurological Test (motor, sensory, reflex, and balance assessments) and body weight loss recovery at 1 and 2 days after injury. Analysis of variance with Bonferroni correction assessed intergroup differences ( p < 0.05).
RESULTS: One-hour, but not 24-hour, TXA improved Garcia Neurological Test performance on day 1 post-TBI compared with placebo. Both 1 hour and 24 hours TXA similarly improved day 1 weight loss recovery, but only 1 hour TXA significantly improved weight loss recovery on day 2 compared with placebo ( p = 0.04). No intergroup differences were found in LEU rolling or adhesion between injured animal groups. Compared with untreated injured animals, only TXA at 1 hour reduced BBB permeability.
CONCLUSION: Only early post-TBI TXA consistently improves murine neurological recovery. Tranexamic acid preserves BBB integrity but only when administered early. This effect appears independent of LEU-EC interactions and demonstrates a time-sensitive effect that supports only early TXA administration.
参考来源
- Culkin MC, Bele P, Georges AP, et al. Early posttraumatic brain injury tranexamic acid prevents blood-brain barrier hyperpermeability and improves surrogates of neuroclinical recovery. J Trauma Acute Care Surg. 2023. PMID: 37038259. doi:10.1097/TA.0000000000003971
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。